Cash flow Xunfei Healthcare Technology Co., Ltd.

Stocks

2506

CNE100006MP5

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E. Other stock markets 09:08:21 12/06/2026 BST			5-day change	1st Jan Change
83.65 ^HKD	+2.32%		-0.30%	+5.75%

03-30	Xunfei Healthcare's Loss Narrows 51% in 2025; Shares Slip 5%	MT
03-27	Xunfei Healthcare Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

b4c59.BAEg1r43Nr7T2pp-HgYFuZdwIJ5uARwzx4s0K3TFk0g.cVl6n4gFQ_Oe69EGRG5E6PgWF9c5TntRs9xdU0Gq-yxUVFCy-F1R86uI3w

Published financial data: XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	372M	472M	556M	734M	915M
Total Revenues	372M	472M	556M	734M	915M
Cost of Goods Sold, Total	185M	241M	241M	330M	453M
Gross Profit	188M	231M	315M	404M	462M
Selling General & Admin Expenses, Total	160M	269M	276M	288M	309M
Provision for Bad Debts	154K	8.76M	5.83M	12.4M	34.54M
R&D Expenses	160M	242M	264M	272M	245M
Other Operating Expenses, Total	320M	520M	545M	572M	588M
Operating Income	-132M	-289M	-231M	-168M	-127M
Interest Expense, Total	-2.9M	-590K	-1.21M	-6.14M	-11.44M
Interest And Investment Income	1.81M	3.14M	7.96M	6.42M	11.15M
Net Interest Expenses	-1.09M	2.55M	6.75M	278K	-293K
Income (Loss) On Equity Invest.	-	-	-	-	-2.86M
Currency Exchange Gains (Loss)	-	-	-	-	5.47M
Other Non Operating Income (Expenses)	22.47M	39.55M	36.22M	-4.43M	28.36M
EBT, Excl. Unusual Items	-111M	-247M	-188M	-172M	-96.07M
Gain (Loss) On Sale Of Investments	-	2.73M	904K	318K	120K
Gain (Loss) On Sale Of Assets	-144K	12K	-33K	-18K	-36K
Other Unusual Items	-	-	-	25K	-
EBT, Incl. Unusual Items	-111M	-244M	-187M	-172M	-95.98M
Income Tax Expense	-21.57M	-35.5M	-32.69M	-34.38M	-30.22M
Earnings From Continuing Operations	-89.4M	-209M	-154M	-138M	-65.77M
Net Income to Company	-89.4M	-209M	-154M	-138M	-65.77M
Minority Interest	5.69M	19.2M	9.38M	5.04M	979K
Net Income - (IS)	-83.71M	-189M	-145M	-133M	-64.79M
Net Income to Common Incl Extra Items	-83.71M	-189M	-145M	-133M	-64.79M
Net Income to Common Excl. Extra Items	-83.71M	-189M	-145M	-133M	-64.79M
Per Share Items
Net EPS - Basic	-0.9	-1.71	-1.3	-1.16	-0.54
Basic EPS - Continuing Operations	-0.9	-1.71	-1.3	-1.16	-0.54
Basic Weighted Average Shares Outstanding	93.36M	111M	111M	114M	121M
Net EPS - Diluted	-0.9	-1.71	-1.3	-1.16	-0.54
Diluted EPS - Continuing Operations	-0.9	-1.71	-1.3	-1.16	-0.54
Diluted Weighted Average Shares Outstanding	93.36M	111M	111M	114M	121M
Normalized Basic EPS	-0.68	-1.22	-0.97	-0.9	-0.49
Normalized Diluted EPS	-0.68	-1.22	-0.97	-0.9	-0.49
Supplemental Items
EBITDA	-103M	-251M	-205M	-136M	-94.79M
EBITA	-105M	-255M	-212M	-145M	-104M
EBIT	-132M	-289M	-231M	-168M	-127M
Effective Tax Rate - (Ratio)	19.44	14.55	17.49	19.99	31.48
Current Domestic Taxes	-	-	-	1.66M	318K
Total Current Taxes	-	-	-	1.66M	318K
Deferred Domestic Taxes	-21.57M	-35.5M	-32.69M	-36.04M	-30.54M
Total Deferred Taxes	-21.57M	-35.5M	-32.69M	-36.04M	-30.54M
Normalized Net Income	-63.57M	-135M	-108M	-103M	-59.06M
Interest on Long-Term Debt	122K	82K	35K	145K	245K
Supplemental Operating Expense Items
Advertising Expense	3.44M	8.14M	16.76M	-	-
Selling and Marketing Expenses	90.65M	160M	163M	192M	207M
General and Administrative Expenses	69.35M	109M	113M	95.88M	102M
Research And Development Expense From Footnotes	160M	242M	264M	272M	245M
Stock-Based Comp., COGS (Total)	-	-	-	-	19.51M
Stock-Based Comp., R&D Exp. (Total)	9.91M	26.38M	25.12M	-	-
Stock-Based Comp., S&M Exp. (Total)	4.43M	13.23M	11.58M	-	-
Stock-Based Comp., G&A Exp. (Total)	20.56M	57.04M	56.63M	-	-
Stock-Based Comp., Other (Total)	-	-	-	54.63M	7.27M
Total Stock-Based Compensation	34.9M	96.65M	93.33M	54.63M	26.78M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	434M	163M	143M	677M	124M
Trading Asset Securities, Total	-	85M	25M	-	-
Total Cash And Short Term Investments	434M	248M	168M	677M	124M
Accounts Receivable, Total	183M	290M	506M	752M	1.05B
Other Receivables	66.19M	47.72M	83.28M	98.54M	93.37M
Total Receivables	249M	338M	590M	850M	1.15B
Inventory	32.36M	46.89M	73.53M	103M	131M
Other Current Assets, Total	11.65M	19.31M	22.42M	51.35M	282M
Total Current Assets	727M	652M	853M	1.68B	1.68B
Gross Property Plant And Equipment	21.04M	24.4M	35.4M	49.47M	61.53M
Accumulated Depreciation	-9.76M	-13.08M	-19.8M	-27.81M	-36.11M
Net Property Plant And Equipment	11.27M	11.32M	15.6M	21.66M	25.41M
Long-term Investments	-	-	-	-	165M
Goodwill	23.78M	23.78M	23.78M	23.78M	23.78M
Other Intangibles, Total	182M	154M	144M	116M	154M
Accounts Receivable Long-Term	-	99.79M	79.2M	76.2M	42.12M
Deferred Tax Assets Long-Term	42.81M	74.83M	106M	140M	168M
Deferred Charges Long-Term	23.08M	11.68M	14.02M	29.2M	25.64M
Other Long-Term Assets, Total	3.4M	1.9M	1.88M	1.88M	26.47M
Total Assets	1.01B	1.03B	1.24B	2.09B	2.31B
Liabilities
Accounts Payable, Total	110M	211M	281M	399M	559M
Accrued Expenses, Total	51.89M	72.5M	86.79M	117M	113M
Current Portion of Long-Term Debt	77.08M	-	88M	180M	141M
Current Portion of Leases	1.77M	731K	1.05M	4.67M	4.07M
Current Income Taxes Payable	-	-	-	-	1.79M
Unearned Revenue Current, Total	51.75M	31.47M	42.03M	35.18M	35.95M
Other Current Liabilities	195M	287M	172M	264M	335M
Total Current Liabilities	488M	603M	671M	1B	1.19B
Long-Term Debt	-	-	-	64.8M	136M
Long-Term Leases	719K	-	504K	4.64M	2.17M
Unearned Revenue Non Current	-	-	-	19.3M	24.9M
Deferred Tax Liability Non Current	20.48M	18.34M	16.2M	14.07M	11.93M
Other Non Current Liabilities	8.07M	8.07M	-	-	-
Total Liabilities	517M	630M	688M	1.1B	1.36B
Common Stock, Total	36.95M	111M	114M	121M	121M
Additional Paid In Capital	405M	341M	548M	1.06B	1.06B
Retained Earnings	-54.6M	-244M	-389M	-521M	-586M
Comprehensive Income and Other	38.89M	133M	225M	279M	301M
Total Common Equity	427M	341M	499M	940M	897M
Minority Interest	70.47M	58.51M	51.07M	46.94M	51.28M
Total Equity	497M	400M	550M	987M	948M
Total Liabilities And Equity	1.01B	1.03B	1.24B	2.09B	2.31B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	93.36M	111M	114M	121M	121M
ECS Total Common Shares Outstanding	93.36M	111M	114M	121M	121M
Book Value / Share	4.57	3.07	4.38	7.78	7.42
Tangible Book Value	220M	163M	331M	800M	719M
Tangible Book Value Per Share	2.36	1.47	2.9	6.62	5.95
Total Debt	79.57M	731K	89.55M	254M	283M
Net Debt	-355M	-247M	-77.95M	-423M	159M
Minority Interest, Total (Incl. Fin. Div)	70.47M	58.51M	51.07M	46.94M	51.28M
Equity Method Investments, Total	-	-	-	-	162M
Account Code - Inventory Valuation	-	-	3	3	6
Inventories - Raw Materials, Total	2.51M	5.9M	2.21M	5.63M	6.88M
Inventories - Finished Goods, Total	996K	2.24M	10.14M	19.18M	28.75M
Inventories - Others	28.86M	38.75M	61.17M	78.05M	95.8M
Machinery, Total	18.16M	23.26M	29.4M	36.1M	51.14M
Full Time Employees	-	-	-	911	1.04K
Accumulated Allowance for Doubtful Accounts (Supple)	825K	5.43M	11.73M	24.18M	56.55M
Order Backlog	99.4M	185M	181M	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-83.71M	-189M	-145M	-133M	-64.79M
Depreciation & Amortization - CF	4.28M	5.69M	8.59M	10.24M	12.05M
Amortization of Goodwill and Intangible Assets - (CF)	26.73M	34.3M	19.13M	23.44M	22.95M
Depreciation & Amortization, Total	31.01M	39.99M	27.72M	33.68M	35M
Amortization of Deferred Charges, Total - (CF)	5.94M	14.24M	14.24M	14.24M	14.24M
(Gain) Loss From Sale Of Asset	144K	-12K	33K	-7K	36K
(Gain) Loss on Sale of Investments - (CF)	-	-2.73M	-904K	-318K	-120K
(Income) Loss On Equity Investments - (CF)	-	-	-	-	2.86M
Stock-Based Compensation (CF)	34.9M	96.65M	93.33M	54.63M	26.78M
Provision and Write-off of Bad Debts	628K	8.6M	6.19M	13.4M	35.52M
Other Operating Activities, Total	3.38M	-22.11M	-17.65M	-2.27M	39.02M
Change In Accounts Receivable	-67.22M	-128M	-179M	-268M	-333M
Change In Inventories	-7.94M	-14.52M	-26.64M	-29.32M	-28.58M
Change In Accounts Payable	73.22M	124M	85.07M	148M	164M
Change in Unearned Revenues	-5.71M	-20.28M	10.56M	-4.24M	6.37M
Change in Other Net Operating Assets	-37.32M	-19.79M	-183M	38.63M	59.78M
Cash from Operations	-52.68M	-114M	-314M	-134M	-42.97M
Capital Expenditure	-6.06M	-5.98M	-10.82M	-8.08M	-42.31M
Sale of Property, Plant, and Equipment	133K	261K	6K	16K	2K
Cash Acquisitions	-55.44M	-	-24.2M	-8.07M	-
Sale (Purchase) of Intangible assets	-22.52M	-9.08M	-25.68M	-24.95M	-71.09M
Investment in Marketable and Equity Securities, Total	-	-82.27M	60.9M	25.32M	-429M
Net (Increase) Decrease in Loans Originated / Sold - Investing	22.14M	-	-	-	-
Other Investing Activities, Total	4.2M	3.8M	264K	11.5M	16.21M
Cash from Investing	-57.56M	-93.28M	465K	-4.26M	-526M
Long-Term Debt Issued, Total	256M	-	128M	340M	525M
Total Debt Issued	256M	-	128M	340M	525M
Long-Term Debt Repaid, Total	-204M	-78.84M	-41.26M	-184M	-497M
Total Debt Repaid	-204M	-78.84M	-41.26M	-184M	-497M
Issuance of Common Stock	395M	10M	210M	539M	-
Other Financing Activities, Total	-2.19M	4.84M	-3.42M	-22.97M	-12.32M
Cash from Financing	445M	-64M	293M	673M	16.32M
Net Change in Cash	334M	-271M	-20.51M	534M	-553M
Supplemental Items
Cash Interest Paid	1.34M	590K	2.76M	6M	11.2M
Cash Income Tax Paid (Refund)	-3.55M	19K	-111K	65K	187K
Levered Free Cash Flow	-	37.82M	-349M	-125M	-449M
Unlevered Free Cash Flow	-	38.19M	-348M	-121M	-442M
Change In Net Working Capital	-	-82.96M	302M	85.17M	325M
Net Debt Issued / Repaid	52.32M	-78.84M	86.74M	156M	28.64M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-	-17.67	-12.72	-6.32	-3.6
Return on Total Capital	-	-36.96	-27.74	-11.18	-6.41
Return On Equity %	-	-46.52	-32.48	-17.91	-6.8
Return on Common Equity	-	-49.34	-34.49	-18.43	-7.06
Margin Analysis
Gross Profit Margin %	50.4	48.88	56.58	55.05	50.45
SG&A Margin	42.96	57.06	49.56	39.24	33.73
EBITDA Margin %	-27.56	-53.13	-36.78	-18.55	-10.36
EBITA Margin %	-28.32	-53.96	-38.05	-19.72	-11.34
EBIT Margin %	-35.5	-61.23	-41.49	-22.91	-13.85
Income From Continuing Operations Margin %	-24	-44.21	-27.73	-18.75	-7.19
Net Income Margin %	-22.47	-40.14	-26.04	-18.07	-7.08
Net Avail. For Common Margin %	-22.47	-40.14	-26.04	-18.07	-7.08
Normalized Net Income Margin	-17.07	-28.63	-19.42	-13.99	-6.46
Levered Free Cash Flow Margin	-	8.02	-62.69	-16.98	-49.05
Unlevered Free Cash Flow Margin	-	8.09	-62.55	-16.45	-48.27
Asset Turnover
Asset Turnover	-	0.46	0.49	0.44	0.42
Fixed Assets Turnover	-	41.77	41.33	39.4	38.88
Receivables Turnover (Average Receivables)	-	2	1.4	1.17	1.01
Inventory Turnover (Average Inventory)	-	6.09	4.01	3.74	3.87
Short Term Liquidity
Current Ratio	1.49	1.08	1.27	1.68	1.41
Quick Ratio	1.4	0.97	1.13	1.53	1.07
Operating Cash Flow to Current Liabilities	-0.11	-0.19	-0.47	-0.13	-0.04
Days Sales Outstanding (Average Receivables)	-	182.81	261.36	313.68	359.71
Days Outstanding Inventory (Average Inventory)	-	59.97	91.01	97.84	94.31
Average Days Payable Outstanding	-	229.46	335.25	346.57	363.04
Cash Conversion Cycle (Average Days)	-	13.32	17.12	64.95	90.99
Long Term Solvency
Total Debt/Equity	16.01	0.18	16.29	25.75	29.86
Total Debt / Total Capital	13.8	0.18	14.01	20.48	22.99
LT Debt/Equity	0.14	-	0.09	7.04	14.59
Long-Term Debt / Total Capital	0.12	-	0.08	5.6	11.24
Total Liabilities / Total Assets	50.97	61.17	55.57	52.78	59.01
EBIT / Interest Expense	-45.67	-489.72	-190.55	-27.39	-11.08
EBITDA / Interest Expense	-34.96	-421.94	-167.66	-21.91	-8.02
(EBITDA - Capex) / Interest Expense	-37.05	-432.08	-176.6	-23.22	-11.72
Total Debt / EBITDA	-0.79	-0	-0.44	-1.89	-3.08
Net Debt / EBITDA	3.5	0.99	0.38	3.14	-1.74
Total Debt / (EBITDA - Capex)	-0.74	-0	-0.42	-1.78	-2.11
Net Debt / (EBITDA - Capex)	3.31	0.97	0.36	2.96	-1.19
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	26.69	17.86	31.98	24.66
Gross Profit, 1 Yr. Growth %	-	22.87	36.41	28.42	14.24
EBITDA, 1 Yr. Growth %	-	144.23	-18.4	-33.42	-30.4
EBITA, 1 Yr. Growth %	-	141.41	-16.89	-31.6	-28.29
EBIT, 1 Yr. Growth %	-	118.54	-20.14	-27.11	-24.64
Earnings From Cont. Operations, 1 Yr. Growth %	-	133.33	-26.07	-10.76	-52.22
Net Income, 1 Yr. Growth %	-	126.27	-23.53	-8.45	-51.14
Normalized Net Income, 1 Yr. Growth %	-	112.48	-20.06	-4.91	-42.48
Diluted EPS Before Extra, 1 Yr. Growth %	-	90.32	-23.61	-10.66	-53.98
Accounts Receivable, 1 Yr. Growth %	-	58.8	74.61	48.43	39.92
Inventory, 1 Yr. Growth %	-	44.87	56.82	39.88	27.79
Net Property, Plant and Equip., 1 Yr. Growth %	-	0.39	37.79	38.88	17.33
Total Assets, 1 Yr. Growth %	-	1.56	20.21	68.87	10.64
Tangible Book Value, 1 Yr. Growth %	-	-25.99	102.74	141.83	-10.1
Common Equity, 1 Yr. Growth %	-	-20	46.17	88.44	-4.61
Cash From Operations, 1 Yr. Growth %	-	116.27	175.87	-57.33	-67.96
Capital Expenditures, 1 Yr. Growth %	-	-1.32	80.96	-25.38	423.85
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-1.02K	-64.26	260.22
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-1.01K	-65.28	265.75
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	22.19	24.72	28.27
Gross Profit, 2 Yr. CAGR %	-	-	29.46	32.36	21.13
EBITDA, 2 Yr. CAGR %	-	-	41.17	-26.29	-31.93
EBITA, 2 Yr. CAGR %	-	-	41.65	-24.6	-29.96
EBIT, 2 Yr. CAGR %	-	-	32.11	-23.7	-25.89
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	31.34	-18.77	-34.7
Net Income, 2 Yr. CAGR %	-	-	31.54	-16.33	-33.12
Normalized Net Income, 2 Yr. CAGR %	-	-	30.33	-12.81	-26.04
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	20.58	-17.39	-35.88
Accounts Receivable, 2 Yr. CAGR %	-	-	66.52	60.99	44.11
Inventory, 2 Yr. CAGR %	-	-	50.73	48.11	33.7
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	17.61	38.34	27.65
Total Assets, 2 Yr. CAGR %	-	-	10.49	42.47	36.69
Tangible Book Value, 2 Yr. CAGR %	-	-	22.49	121.42	47.44
Common Equity, 2 Yr. CAGR %	-	-	8.13	65.96	34.07
Cash From Operations, 2 Yr. CAGR %	-	-	144.26	8.5	-63.02
Capital Expenditures, 2 Yr. CAGR %	-	-	33.63	16.2	97.71
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	81.5	13.47
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	77.82	12.68
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	25.37	24.7
Gross Profit, 3 Yr. CAGR %	-	-	-	29.12	26.02
EBITDA, 3 Yr. CAGR %	-	-	-	9.88	-27.69
EBITA, 3 Yr. CAGR %	-	-	-	11.13	-25.85
EBIT, 3 Yr. CAGR %	-	-	-	8.35	-24.02
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	15.47	-31.94
Net Income, 3 Yr. CAGR %	-	-	-	16.57	-30.06
Normalized Net Income, 3 Yr. CAGR %	-	-	-	17.33	-24.1
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	9.11	-32.02
Accounts Receivable, 3 Yr. CAGR %	-	-	-	60.26	53.64
Inventory, 3 Yr. CAGR %	-	-	-	47.02	41
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	24.31	30.95
Total Assets, 3 Yr. CAGR %	-	-	-	27.27	30.96
Tangible Book Value, 3 Yr. CAGR %	-	-	-	53.67	63.96
Common Equity, 3 Yr. CAGR %	-	-	-	30.13	37.99
Cash From Operations, 3 Yr. CAGR %	-	-	-	36.55	-27.75
Capital Expenditures, 3 Yr. CAGR %	-	-	-	10.04	91.96
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	128.09
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	126.14